zepbound and tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply access for adults living with obesity Which Weight-Loss Drug Works the

One recent analysis of six years of medical records from the Department of Veterans Affairs, which reviewed the records of 2 million patients with diabetes, found that those taking a GLP-1 agonist medication had a reduced risk of developing dementia, including Alzheimers, as well as psychiatric and substance use disorders, though it also found an increased risk of gastrointestinal disorders, kidney stones, and pancreatitis

Read article 15 June 2026 Eggs are low in carbs and usually do not raise blood sugar much

We serve patients across Pennsylvania via telehealth, including Philadelphia, Pittsburgh, Allentown, Reading, Harrisburg, Lancaster, Scranton, Erie, Bethlehem, and York, among other areas statewide

Do not shake the vial vigorously